CDTX vs. COGT
CDTX (Cidara Therapeutics, Inc.) and COGT (Cogent Biosciences, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. At a 0.18 correlation, their price movements are largely independent.
Performance
CDTX vs. COGT - Performance Comparison
Loading charts...
Returns By Period
CDTX
- 1D
- —
- 1M
- —
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
COGT
- 1D
- -1.53%
- 1M
- -12.17%
- YTD
- -9.18%
- 6M
- -17.62%
- 1Y
- 457.17%
- 3Y*
- 35.49%
- 5Y*
- 32.16%
- 10Y*
- —
CDTX vs. COGT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
CDTX Cidara Therapeutics, Inc. | 0.22% | 721.76% | 69.27% | 4.98% | -40.45% | -36.50% | -47.92% | 63.40% | -41.25% |
COGT Cogent Biosciences, Inc. | -9.18% | 355.38% | 32.65% | -49.13% | 34.73% | -23.60% | 289.93% | -83.64% | -60.40% |
Correlation
The correlation between CDTX and COGT is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.13 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.17 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.18 |
Correlation (All Time) Calculated using the full available price history since Apr 2, 2018 | 0.18 |
Fundamentals
CDTX:
$3.44B
COGT:
$2.17B
CDTX:
-$11.88
COGT:
-$3.89
CDTX:
8.15
COGT:
3.76
CDTX:
$0.00
COGT:
$0.00
CDTX:
-$45.00M
COGT:
-$2.33M
CDTX:
-$189.91M
COGT:
-$363.18M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CDTX vs. COGT — Risk / Return Rank
CDTX
COGT
CDTX vs. COGT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Cidara Therapeutics, Inc. (CDTX) and Cogent Biosciences, Inc. (COGT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Sharpe Ratios by Period
| CDTX | COGT | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | 3.53 | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.34 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | — | -0.02 | — |
Drawdowns
CDTX vs. COGT - Drawdown Comparison
Loading charts...
Drawdown Indicators
| CDTX | COGT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | — | -98.09% | — |
Max Drawdown (1Y)Largest decline over 1 year | — | -25.79% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -69.87% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -76.34% | — |
Current DrawdownCurrent decline from peak | — | -51.91% | — |
Average DrawdownAverage peak-to-trough decline | — | -77.82% | — |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 10.29% | — |
Volatility
CDTX vs. COGT - Volatility Comparison
Loading charts...
Volatility by Period
| CDTX | COGT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 12.42% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 31.76% | — |
Volatility (1Y)Calculated over the trailing 1-year period | — | 130.68% | — |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | — | 95.04% | — |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | — | 166.35% | — |
Dividends
CDTX vs. COGT - Dividend Comparison
Neither CDTX nor COGT has paid dividends to shareholders.
Financials
CDTX vs. COGT - Financials Comparison
This section allows you to compare key financial metrics between Cidara Therapeutics, Inc. and Cogent Biosciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CDTX and COGT have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for CDTX and COGT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer